VYCELLIX
Vycellix, Inc., is a closely-held immunotherapy-focused, discovery company with the mission to fundamentally impact the challenges that currently prevail in the area of cell & gene based-therapies. The Company is engaged in the development of proprietary approaches for cell-based immunotherapeutic products and to improve patient outcomes.
VYCELLIX
Industry:
Pharmaceutical
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.vycellix.com
Total Employee:
11+
Status:
Active
Contact:
(772) 418-6302
Email Addresses:
[email protected]
Technology used in webpage:
Euro Google Maps Cloudflare Hosting JotForm
Similar Organizations
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Targepeutics
Targepeutics Inc. is a biopharmaceutical company.
Current Advisors List
Current Employees Featured
Investors List
Florida Opportunity Fund
Florida Opportunity Fund investment in Series A - Vycellix
Vinnova
Vinnova investment in Grant - Vycellix
Official Site Inspections
http://www.vycellix.com Semrush global rank: 7.1 M Semrush visits lastest month: 890
- Host name: 172.67.204.16
- IP address: 172.67.204.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vycellix"
Vycellix – Immuno-Discoveries with Universal Impact
Discover our novel platforms to optimize and enhance cell & gene based-therapies. Meet our team of experts working on our revolutionary science and advisory board. Contact us to learn …See details»
About Us - Vycellix
Vycellix, Inc. is a private, immuno-centric discovery life science company, advancing the development of transformational platform technologies to enhance and optimize next …See details»
Vycellix - Crunchbase Company Profile & Funding
Vycellix, Inc., is a closely-held immunotherapy-focused, discovery company with the mission to fundamentally impact the challenges that currently prevail in the area of cell & gene based …See details»
Vycellix Company Profile 2024: Valuation, Funding & Investors
Operator of a cell-based immunotherapy company intended to overcome limitations of current cell and gene therapies. The company offers novel platforms to optimize and enhance cell and …See details»
Board of Directors – Vycellix
Mr. Adams is Co-founder & Partner at MintPharma Capital, which led Vycellix’s most recent March 2024 funding round. He has more than 30 years of experience in investment management. Currently, he serves as the managing partner of …See details»
Biotech research company to set up U.S. headquarters near …
Feb 22, 2019 · Vycellix, which works to create new cell- and gene-based cancer therapies, will start in April to the University Park Business Center on E Fowler Avenue, near the H. Lee …See details»
Vycellix - VentureRadar
Vycellix, Inc., is a closely-held immunotherapy-focused, discovery company with the mission to fundamentally impact the challenges that currently prevail in the area of cell & gene based …See details»
Vycellix - Products, Competitors, Financials, Employees, …
Vycellix develops cellular immunotherapies in the healthcare and biotechnology sectors. The company offers novel platforms to optimize and enhance cell- and gene-based therapies, …See details»
Vycellix Presents Proof-of-Concept Data for VY-UC …
Jun 5, 2023 · TAMPA, FLORIDA & STOCKHOLM, SWEDEN – June 5, 2023 – Vycellix, Inc., a transformational cell and gene engineering company with the mission to integrate its process-enhancing tools into the development and …See details»
Vycellix - Overview, News & Similar companies | ZoomInfo.com
Aug 19, 2021 · View Vycellix (www.vycellix.com) location in Florida, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Vycellix And H. Lee Moffitt Cancer Center & Research ... - BioSpace
Feb 27, 2017 · Vycellix, Inc. is a closely-held biotechnology company advancing innovative products designed to enhance cellular therapies, facilitate manufacturing processes and …See details»
Vycellix CEO to Present its Universal Cell Program (VY-UC) for Off …
Oct 22, 2020 · Vycellix, Inc., an immuno-centric discovery life science company with a focus on natural killer cell-based (NK cell) therapeutics, today announced that its Chairman & CEO, …See details»
Vycellix CEO to Present its Universal Cell Program (VY-UC) for Off …
Oct 22, 2020 · Vycellix is a private, immuno-centric discovery life science company, advancing the development of transformational platform technologies to enhance and optimize next …See details»
Vycellix Company Profile - Office Locations, Competitors ... - Craft
See insights on Vycellix including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Vycellix Presents Proof-of-Concept Data for VY-UC Allogeneic
Jun 5, 2023 · Vycellix, Inc. today announced that its founding Chairman & CEO, Evren Alici, M.D., Ph.D., presented pre-clinical, proof-of-concept results for the Company’s single-step approach …See details»
VY-201 - Drug Targets, Indications, Patents - Synapse - Patsnap
VY-201, Initially developed by Vycellix, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms, Active Indication: Sarcoma, Active Org.: Vycellix, Inc.. …See details»
News - Vycellix
TAMPA, FLORIDA & STOCKHOLM, SWEDEN – March 23, 2021 – Vycellix, Inc., an immuno-centric discovery life science company with a focus on natural killer cell-based (NK cell) …See details»
Vycellix Presents Proof-of-Concept Data for VY-UC Allogeneic Cell ...
Jun 5, 2023 · Headquartered in Tampa, Florida, with scientific operations in Stockholm, Sweden, Vycellix has developed a broad suite of cell therapy engineering solutions with the mission to …See details»
Research programme: cellular therapeutics - Vycellix
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. Cell therapies for the treatment of cancers and infectious diseases are being …See details»
Vycellix CEO to Present Next-Generation Universal Cell Platform to ...
TAMPA, FLORIDA & STOCKHOLM, SWEDEN – August 10, 2020 – Vycellix, Inc., an immuno-centric discovery life science company with a focus on natural killer cell-based (NK cell) …See details»